SCHEMBL2477665

SCHEMBL2477665

Cc1cc2ccnc(Cl)c2n1CCOCc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 1/20 0.43
DYRK1A Q13627 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MEN1 O00255 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38
LTA4H P09960 1/20 0.38
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
CYP1A2 P05177 4/20 0.35
CYP3A4 P08684 2/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
CYP2C19 P33261 3/20 0.34
CYP2D6 P10635 1/20 0.34
POLB P06746 1/20 0.34
KDM4E B2RXH2 1/20 0.34
CYP2C9 P11712 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2475184 0.82 TYMS (0.46) DYRK1AALDH1A1MEN1KMT2ACYP1A2
SCHEMBL2473043 0.82 MCL1 (0.40) MCL1ALDH1A1MEN1NPC1RAB9A
SCHEMBL2476713 0.81 CASR (0.38) DYRK1AALDH1A1MEN1KMT2ACYP1A2
SCHEMBL2475293 0.76 KDM4E (0.44) DYRK1AALDH1A1MEN1KMT2ATSHR
SCHEMBL2473124 0.74 KDM4E (0.43) DYRK1AALDH1A1MEN1KMT2ACYP1A2
SCHEMBL2479489 0.74 KDM4E (0.44) DYRK1AALDH1A1MEN1KMT2ACYP1A2
SCHEMBL2477064 0.71 GABRA5 (0.46) ALDH1A1MEN1KMT2ACYP1A2CYP3A4
SCHEMBL22165760 0.71 ALDH1A1 (0.46) ALDH1A1MEN1KMT2ALTA4HMAOA
SCHEMBL2475307 0.70 ALDH1A1 (0.51) DYRK1AALDH1A1KDM4ESMN1; SMN2
SCHEMBL2474620 0.70 HTR2A (0.32) DYRK1AALDH1A1MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1787991-B2 PYRROLO[2,3-c]PYRIDINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE TAKEDA PHARMACEUTICALS CO (JP) 2020-06-24 EP disclosed
US-20180148446-A1 PYRROLO [2,3-c] PYRIDINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE TAKEDA PHARMACEUTICALS CO (JP) 2018-05-31 US disclosed
EP-1787991-B1 PYRROLO[2,3-c]PYRIDINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE TAKEDA PHARMACEUTICAL (JP) 2011-10-05 EP disclosed
US-20070293532-A1 Pyrrolo [2,3-C] Pyridine Compound, Process for Producing the Same, and Use TAKEDA PHARMACEUTICAL COMPAN6Y LIMITED (JP) 2007-12-20 US disclosed
EP-1787991-A1 PYRROLOÝ2,3-c¨PYRIDINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE Takeda Pharmaceutical Company Limited (JP) 2007-05-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180148446-A1 PYRROLO [2,3-c] PYRIDINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE PGA5, ATP6AP1, PPA1 MCL1 2577/4885DYRK1A 2882/4885ALDH1A1 1988/4885
US-20070293532-A1 Pyrrolo [2,3-C] Pyridine Compound, Process for Producing the Same, and Use PGA5, ATP6AP1, PPA1 MCL1 2577/4885DYRK1A 2882/4885ALDH1A1 1988/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.